Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 3/20 | 0.78 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | RARA | P10276 | 2/20 | 0.36 |
| ▸ | RARB | P10826 | 2/20 | 0.36 |
| ▸ | RARG | P13631 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.35 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3024232 | 0.92 | CNR2 (0.66) | CNR2CNR1CYP2C9CYP2D6HIF1A | |
| SCHEMBL15428814 | 0.88 | CNR2 (1.00) | CNR2CNR1CYP2C9CYP2D6TSHR | |
| SCHEMBL17889676 | 0.88 | CNR2 (1.00) | CNR2CNR1CYP2C9CYP2D6TSHR | |
| SCHEMBL3016208 | 0.88 | CNR2 (1.00) | CNR2CNR1CYP2C9CYP2D6TSHR | |
| SCHEMBL3020924 | 0.87 | CNR2 (0.71) | CNR2TSHRALDH1A1RARARARB | |
| SCHEMBL13211746 | 0.79 | CNR2 (0.84) | CNR2CNR1CYP2C9CYP2D6TSHR | |
| SCHEMBL14942535 | 0.78 | CNR2 (0.82) | CNR2CNR1CYP2C9CYP2D6TSHR | |
| SCHEMBL13211749 | 0.78 | CNR2 (0.82) | CNR2CNR1CYP2C9ALDH1A1GAA | |
| SCHEMBL3019867 | 0.78 | CNR2 (0.71) | CNR2TSHRALDH1A1RARARARB | |
| SCHEMBL3007800 | 0.78 | CNR2 (0.81) | CNR2CYP2C9CYP2D6TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230404990-A1 | NEUROPROTECTIVE CB2 RECEPTOR AGONISTS | CLEVELAND CLINIC FOUND (US) | 2023-12-21 | — | — | US | disclosed |
| US-20220047568-A1 | NEUROPROTECTIVE CB2 RECEPTOR AGONISTS | CLEVELAND CLINIC FOUND (US) | 2022-02-17 | — | — | US | disclosed |
| US-11160798-B2 | Neuroprotective CB2 receptor agonists | THE CLEVELAND CLINIC FOUNDATION (US) | 2021-11-02 | — | — | US | disclosed |
| US-10835521-B2 | Neuroprotective CB2 receptor agonists | THE CLEVELAND CLINIC FOUNDATION (US) | 2020-11-17 | — | — | US | disclosed |
| EP-3735239-A1 | ORAL CANNABINOID RECEPTOR MODULATOR FORMULATIONS | THE CLEVELAND CLINIC FOUNDATION (US) | 2020-11-11 | — | — | EP | disclosed |
| US-20200087288-A1 | ORAL CANNABINOID RECEPTOR MODULATOR FORMULATIONS | CLEVELAND CLINIC FOUND (US) | 2020-03-19 | — | — | US | disclosed |
| US-20200085811-A1 | NEUROPROTECTIVE CB2 RECEPTOR AGONISTS | THE CLEVELAND CLINIC FOUNDATION | 2020-03-19 | — | — | US | disclosed |
| US-20190210999-A1 | ORAL CANNABINOID RECEPTOR MODULATOR FORMULATIONS | THE CLEVELAND CLINIC FOUNDATION | 2019-07-11 | — | — | US | disclosed |
| WO-2019136331-A1 | ORAL CANNABINOID RECEPTOR MODULATOR FORMULATIONS | THE CLEVELAND CLINIC FOUNDATION (US) | 2019-07-11 | — | — | WO | disclosed |
| US-9394267-B2 | Heterocyclic modulators of cannabinoid receptors | THE CLEVELAND CLINIC FOUNDATION (US) | 2016-07-19 | — | — | US | disclosed |
| US-9339486-B2 | Heterocyclic modulators of cannabinoid receptors | THE CLEVELAND CLINIC FOUNDATION (US) | 2016-05-17 | — | — | US | disclosed |
| US-20150148408-A1 | HETEROCYCLIC MODULATORS OF CANNABINOID RECEPTORS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2015-05-28 | — | — | US | disclosed |
| EP-2872138-A2 | NEUROPROTECTIVE CB2 RECEPTOR AGONISTS | THE CLEVELAND CLINIC FOUNDATION (US) | 2015-05-20 | — | — | EP | disclosed |
| WO-2014011949-A2 | NEUROPROTECTIVE CB2 RECEPTOR AGONISTS | THE CLEVELAND CLINIC FOUNDATION (US) | 2014-01-16 | — | — | WO | disclosed |
| EP-2178371-B1 | HETEROCYCLIC MODULATORS OF CANNABINOID RECEPTORS | UNIV TEXAS (US) | 2014-01-01 | — | — | EP | disclosed |
| US-20130237536-A1 | HETEROCYCLIC MODULATORS OF CANNABINOID RECEPTORS | THE CLEVELAND CLINIC FOUNDATION (US) | 2013-09-12 | — | — | US | disclosed |
| US-8440832-B2 | Heterocyclic modulators of cannabinoid receptors | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2013-05-14 | — | — | US | disclosed |
| US-20100204220-A1 | HETEROCYCLIC MODULATORS OF CANNABINOID RECEPTORS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2010-08-12 | — | — | US | disclosed |
| EP-2178371-A1 | HETEROCYCLIC MODULATORS OF CANNABINOID RECEPTORS | Board of Regents, The University of Texas System (US) | 2010-04-28 | — | — | EP | disclosed |
| WO-2009012221-A1 | HETEROCYCLIC MODULATORS OF CANNABINOID RECEPTORS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2009-01-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204220-A1 | HETEROCYCLIC MODULATORS OF CANNABINOID RECEPTORS | CNR1, CNR2, GPR18 | CNR2 2/4885CNR1 1/4885CYP2C9 727/4885 |
| US-11160798-B2 | Neuroprotective CB2 receptor agonists | CNR1, CNR2, CHRNA2 | CNR2 2/4885CNR1 1/4885CYP2C9 3662/4885 |
| US-20130237536-A1 | HETEROCYCLIC MODULATORS OF CANNABINOID RECEPTORS | CNR1, CNR2, GPR18 | CNR2 2/4885CNR1 1/4885CYP2C9 727/4885 |
| US-20190210999-A1 | ORAL CANNABINOID RECEPTOR MODULATOR FORMULATIONS | CNR1, CNR2, OPRL1 | CNR2 2/4885CNR1 1/4885CYP2C9 570/4885 |
| US-10835521-B2 | Neuroprotective CB2 receptor agonists | CNR1, CNR2, CHRNA2 | CNR2 2/4885CNR1 1/4885CYP2C9 2948/4885 |
| US-20220047568-A1 | NEUROPROTECTIVE CB2 RECEPTOR AGONISTS | CNR1, CNR2, CHRNA2 | CNR2 2/4885CNR1 1/4885CYP2C9 3689/4885 |
| US-20200085811-A1 | NEUROPROTECTIVE CB2 RECEPTOR AGONISTS | CNR1, CNR2, CHRNA2 | CNR2 2/4885CNR1 1/4885CYP2C9 3713/4885 |
| US-20150148408-A1 | HETEROCYCLIC MODULATORS OF CANNABINOID RECEPTORS | CNR1, CNR2, GPR18 | CNR2 2/4885CNR1 1/4885CYP2C9 727/4885 |
| US-20200087288-A1 | ORAL CANNABINOID RECEPTOR MODULATOR FORMULATIONS | CNR1, CNR2, OPRL1 | CNR2 2/4885CNR1 1/4885CYP2C9 570/4885 |
| US-20230404990-A1 | NEUROPROTECTIVE CB2 RECEPTOR AGONISTS | CNR1, CNR2, CHRNA2 | CNR2 2/4885CNR1 1/4885CYP2C9 3079/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.